المؤلفون: Yang, YC, Lu, ML, Rao, JY, Wallerand, H, Cai, L, Cao, W, Pantuck, A, Dalbagni, G, Reuter, V, Figlin, RA, Belldegrun, A, Cordon-Cardo, C, Zhang, ZF

المصدر: British Journal of Cancer. 95(11)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Genetics, Urologic Diseases, Cancer, Aetiology, 2.1 Biological and endogenous factors, Aged, DNA Mutational Analysis, Female, Genes, p53, Humans, Male, Middle Aged, Mutation, Polymorphism, Single Nucleotide, Prognosis, Receptor, Fibroblast Growth Factor, Type 4, Survival Analysis, Survival Rate, Urinary Bladder Neoplasms, bladder cancer, single nucleotide polymorphism, fibroblast growth factor receptor 4, prognosis, TP53 mutation, Public Health and Health Services, Oncology & Carcinogenesis, Oncology and carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/0sx2s2cwTest

المؤلفون: Benedict, A, Figlin, RA, Sandstrom, P, Harmenberg, U, Ullen, A, Charbonneau, C, Sandin, R, Remak, E, Hariharan, S, Negrier, S

المصدر: BJU international. 108(5):665-672

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:123067282Test

المؤلفون: Sullivan, J, Sexton Ward, A, Korytowsky, B, Peneva, D, Benner, J, Lakdawalla, DN, Bolinder, B, Figlin, RA, Jena, AB

المصدر: Value in Health ; volume 19, issue 3, page A167 ; ISSN 1098-3015

مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy

الإتاحة: https://doi.org/10.1016/j.jval.2016.03.1523Test
https://api.elsevier.com/content/article/PII:S1098301516015916?httpAccept=text/plainTest
https://api.elsevier.com/content/article/PII:S1098301516015916?httpAccept=text/xmlTest

المؤلفون: Figlin, RA, Leibovich, BC, Stewart, GD, Negrier, S

مصطلحات موضوعية: Antineoplastic Agents, Carcinoma, Renal Cell, Chemotherapy, Adjuvant, Disease-Free Survival, Humans, Kidney Neoplasms, Molecular Targeted Therapy, Neoplasm Recurrence, Local, Patient Selection, Risk Factors, Treatment Outcome

وصف الملف: Print; application/vnd.openxmlformats-officedocument.wordprocessingml.document

العلاقة: https://www.repository.cam.ac.uk/handle/1810/271506Test

الإتاحة: https://doi.org/10.17863/CAM.18496Test
https://www.repository.cam.ac.uk/handle/1810/271506Test

المؤلفون: Tannir, NM, Figlin, RA, Gore, ME, Michaelson, MD, Motzer, RJ, Porta, C, Rini, BI, Hoang, C, Lin, X, Escudier, B

المساهمون: Gore, Martin, Marsden

وصف الملف: Print-Electronic; image/png

العلاقة: Clinical genitourinary cancer, 2017; https://repository.icr.ac.uk/handle/internal/1113Test

الإتاحة: https://doi.org/10.1016/j.clgc.2017.06.005Test
https://repository.icr.ac.uk/handle/internal/1113Test

المؤلفون: Stewart, GD, Leibovick, BC, Negrier, S, Figlin, RA

المساهمون: Stewart, Grant [0000-0003-3188-9140], Apollo - University of Cambridge Repository

مصطلحات موضوعية: Sulfonamides, Indazoles, Pyrimidines, Humans, Neoplasm Recurrence, Local, urologic and male genital diseases, neoplasms, Carcinoma, Renal Cell, Nephrectomy, female genital diseases and pregnancy complications, Kidney Neoplasms

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52ae26d9fe453effaf00006f0fb0fba7Test

المؤلفون: Stewart, GD, Leibovick, BC, Negrier, S, Figlin, RA

مصطلحات موضوعية: Carcinoma, Renal Cell, Humans, Indazoles, Kidney Neoplasms, Neoplasm Recurrence, Local, Nephrectomy, Pyrimidines, Sulfonamides

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

العلاقة: https://www.repository.cam.ac.uk/handle/1810/271606Test

الإتاحة: https://doi.org/10.17863/CAM.18596Test
https://www.repository.cam.ac.uk/handle/1810/271606Test

المؤلفون: Reckamp, KL, Koczywas, M, Cristea, MC, Dowell, JE, Wang, HJ, Gardner, BK, Milne, GL, Figlin, RA, Fishbein, MC, Elashoff, RM, Dubinett, SM

المصدر: Cancer, vol 121, iss 18
Reckamp, KL; Koczywas, M; Cristea, MC; Dowell, JE; Wang, HJ; Gardner, BK; et al.(2015). Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer. Cancer. doi: 10.1002/cncr.29480. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0sz5x7ftTest

مصطلحات موضوعية: Adult, Male, erlotinib, Lung Neoplasms, DNA Mutational Analysis, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Kaplan-Meier Estimate, Dinoprostone, Disease-Free Survival, Erlotinib Hydrochloride, Double-Blind Method, Clinical Research, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Humans, Oncology & Carcinogenesis, cyclooxygenase 2, Non-Small-Cell Lung, neoplasms, Lung, erbB-1, non-small cell lung cancer, Proportional Hazards Models, Aged, Cancer, prostaglandin E2, celecoxib, Carcinoma, Lung Cancer, Evaluation of treatments and therapeutic interventions, Middle Aged, Immunohistochemistry, Genes, 6.1 Pharmaceuticals, Public Health and Health Services, Female, epidermal growth factor receptor

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fcadddba367296b354cc717282d3c8b5Test
https://escholarship.org/uc/item/0sz5x7ftTest

المؤلفون: MOTZER RJ, ESCUDIER B, OUDARD S, HUTSON TE, PORTA C, BRACARDA S, GRÜNWALD V, THOMPSON JA, FIGLIN RA, HOLLAENDER N, KAY A, RAVAUD A, COLLABORATORS DAVIS I, GURNEY H, PITTMAN K, GOLDSTEIN D, MAINWARING P, KNOX J, ADES S, CHENG T, HOTTE S, KO YJ, MACKENZIE M, NORTH S, CATY A, ROLLAND F, CHEVREAU C, DUCLOS B, BOCCARDO, FRANCESCO, PASSALACQUA, GIOVANNI

المساهمون: Motzer, Rj, Escudier, B, Oudard, S, Hutson, Te, Porta, C, Bracarda, S, Grünwald, V, Thompson, Ja, Figlin, Ra, Hollaender, N, Kay, A, Ravaud, A, COLLABORATORS DAVIS, I, Gurney, H, Pittman, K, Goldstein, D, Mainwaring, P, Knox, J, Ades, S, Cheng, T, Hotte, S, Ko, Yj, Mackenzie, M, North, S, Caty, A, Rolland, F, Chevreau, C, Duclos, B, Boccardo, Francesco, Passalacqua, Giovanni

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/20549832; info:eu-repo/semantics/altIdentifier/wos/WOS:000281507900009; volume:116(18); firstpage:4256; lastpage:4265; numberofpages:10; journal:CANCER; https://hdl.handle.net/11567/215146Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-77956227464

الإتاحة: https://doi.org/10.1002/cncr.25219Test
https://hdl.handle.net/11567/215146Test

المؤلفون: KLATTE T, PATARD JJ, GOEL RH, KLEID MD, GUILLE F, LOBEL B, ABBOU CC, DE LA TAILLE A, TOSTAIN J, CINDOLO L, ALTIERI V, ARTIBANI W., PRAYER GALETTI T, ALLHOFF EP, SCHIPS L, ZIGEUNER R, FIGLIN RA, KABBINAVAR FF, PANTUCK AJ, BELLDEGRUN AS, LAM JS, FICARRA, VINCENZO

المساهمون: Klatte, T, Patard, Jj, Goel, Rh, Kleid, Md, Guille, F, Lobel, B, Abbou, Cc, DE LA TAILLE, A, Tostain, J, Cindolo, L, Altieri, V, Ficarra, Vincenzo, Artibani, W., PRAYER GALETTI, T, Allhoff, Ep, Schips, L, Zigeuner, R, Figlin, Ra, Kabbinavar, Ff, Pantuck, Aj, Belldegrun, A, Lam, Js

مصطلحات موضوعية: renal cell carcinoma, prognostic factors

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000247197000008; volume:178; firstpage:35; lastpage:40; numberofpages:6; journal:THE JOURNAL OF UROLOGY; http://hdl.handle.net/11577/2447963Test

الإتاحة: http://hdl.handle.net/11577/2447963Test